Skip to main content
Clinical Trials/NCT02158923
NCT02158923
Completed
Not Applicable

Postoperative Complication and Hospital Stay Reduction With a Individualized Perioperative Lung Protective Ventilation. A Comparative, Prospective, Multicenter, Randomized Controlled Trial.

Fundación para la Investigación del Hospital Clínico de Valencia7 sites in 4 countries920 target enrollmentSeptember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Moderated-high Risk of Postoperative Pulmonary Complication
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Enrollment
920
Locations
7
Primary Endpoint
Reduction of lung and systemic postoperative complications
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether individualized ventilatory management combining the use of low tidal volumes, alveolar recruitment maneuvers, individually titrated positive end-expiratory pressure and postoperative individualized ventilatory support will decrease postoperative complications, unplanned ICU readmissions, ICU and hospital length of stay and mortality compared to a standardized Lung Protective Ventilation (LPV) for all patients at risk.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
April 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Responsible Party
Principal Investigator
Principal Investigator

Carlos Ferrando

MD, PhD

Fundación para la Investigación del Hospital Clínico de Valencia

Eligibility Criteria

Inclusion Criteria

  • Age not less than 18
  • Risk of postoperative pulmonary complication moderate-high defined by a score ≥ 26 on the risk scale ARISCAT (based on the analysis of seven factors, where a score between 26 and 44 points defines a moderate risk, and a score\> 44 points define a high risk, included in the Information Booklet Investigator).
  • Planned abdominal surgery\> 2 hours.
  • Signed informed consent for participation in the study.

Exclusion Criteria

  • Age less than 18 years.
  • Pregnant or breast-feeding.
  • Patients with BMI \>
  • Syndrome of moderate or severe respiratory distress: PaO2/FiO2 \< 200 mmHg.
  • Heart failure: NYHA IV.
  • Hemodynamic failure: CI \<2.5 L/min/m2 and / or requirements before surgery ionotropic support.
  • Diagnosis or suspicion of intracranial hypertension (intracranial pressure\> 15 mmHg).
  • Mechanical ventilation in the last 15 days.
  • Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT).
  • Patient with preoperatively CPAP.

Outcomes

Primary Outcomes

Reduction of lung and systemic postoperative complications

Time Frame: Up to 7 postoperative days

Secondary Outcomes

  • Reduction of lung and systemic postoperative complications(Up to 30 postoperative days)

Study Sites (7)

Loading locations...

Similar Trials